Where does Anchor Innovation Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Anchor Innovation Medical, Inc. ranks #44,705 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Anchor Innovation Medical, Inc. hold?

Anchor Innovation Medical, Inc. holds 5 US utility patents granted between 2020 and 2025, spanning 4 technology areas.

What is Anchor Innovation Medical, Inc.'s Innovation Score?

Anchor Innovation Medical, Inc. has an Innovation Score of 34.1 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Anchor Innovation Medical, Inc. focus on?

Anchor Innovation Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 3 patents, ranking #941 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Anchor Innovation Medical, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Anchor Innovation Medical, Inc..

What does claim depth mean for Anchor Innovation Medical, Inc.'s patents?

Anchor Innovation Medical, Inc.'s patents average 23.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Anchor Innovation Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Anchor Innovation Medical, Inc.

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Anchor ranks #44,705 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#44,705
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.1/100): 23.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R44705 · US Corporation #44,705 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
LOWER-Q #44,705/49,997
PHOTO-FINISH Anabio
CPC-NARROW A61N · 4 areas
INNOV-THIN 34.1/100
CLAIMS-DENSE 23.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Anabio Technologies Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Anchor’s 34.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (18%) Velocity 6.7 pts (20%) Breadth 7.1 pts (21%) Claim depth 14.2 pts (42%)

Qualcomm Incorporated · highest

85
Anchor Innovation… · this assignee

34
3D Lighting… · lowest

7

What this shows Anchor's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Anchor?

Each dot is one of Anchor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anchor’s own 23.6 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Anchor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Anchor's grants concentrate

Anchor Innovation Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 60% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2022. By volume, Anchor sits between Anabio Technologies Limited and Anhui New Star Pharmaceutical Development Co., Ltd.

Anchor's three-year grant acceleration

Anchor Innovation Medical, Inc. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Anabio

5
Anaeropharma Scie…

5
Analog Modules

5
Anatomacl

5
Anchor Semiconduc…

5
Anchored Rsk3 Inh…

5
Andritz S

5
Anhui New Star Ph…

5
Anchor Innovation… ◀

5

What this shows Anchor holds 5 patents at rank #44,875, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Anchor

By rank, the assignees closest to #44,875 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Anchor's primary technology class.

Anchor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Anchor Innovation Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	40.0%
2022	1	20.0%
2023	1	20.0%
2025partial year	1	20.0%

Which technologies does Anchor Innovation Medical, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Anchor Innovation Medical, Inc.'s patent record in context - here's where to go next.

Anchor Innovation Medical, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 60% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #44,705 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Anchor Innovation Medical, Inc. against Anabio Technologies Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.